2 ML midazolam 5 MG/ML Injection — RxCUI 1666823
RxNorm drug concept · Semantic clinical drug
RxCUI 1666823
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
17 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1666823
Official name2 ML midazolam 5 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmidazolam 10 MG per 2 ML Injection; midazolam 10 MG in 2 ML Injection
FDA products mapped12
Package NDCs mapped17
Reported Medicaid activity (SDUD)106,776 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Midazolam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the form. Injections and the children's syrup are used to calm you, ease anxiety and block memory around procedures or surgery. Injections are also used for anesthesi...
- Injections and the syrup are given by trained staff in monitored settings. The syrup is a single dose before a procedure, not for home use. Nayzilam is sprayed into one nostril, wi...
- Drowsiness, nausea, vomiting and trouble remembering things for several hours are common. Blood pressure may dip slightly. Slow or shallow breathing, severe sleepiness or agitation...
- No, avoid them unless your prescriber says otherwise. Alcohol and opioids can cause dangerously slow breathing, coma and death. Tell your team about every medicine you take, includ...
🕸️ Concept Web — How 2 ML midazolam 5 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
2 ML midazolam 5 MG/ML Injection
RxCUI 1666823 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Midazolam
6960IN
-
Midazolam
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Midazolam Injection
1666797SCDF -
Midazolam Injectable Product
1164715SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Midazolam Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Midazolam 5 MG/ML
330809SCDC
-
Midazolam 5 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Midazolam 5 MG/ML
SCDC · 330809 -
Midazolam Injection
SCDF · 1666797 -
Midazolam Injectable Product
SCDG · 1164715
📦 FDA Products & Package NDCs
12 products · 17 package NDCs
17 package NDCs map to RxCUI 1666823 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00404-9916-01 | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9916-01) / 1 mL in 1 VIA... | Midazolam Hydrochloride | Henry Schein, Inc. | 2022-01-17 |
| 00404-9916-02 | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9916-02) / 2 mL in 1 VIA... | Midazolam Hydrochloride | Henry Schein, Inc. | 2022-01-17 |
| 00409-0001-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (0409-0001-25) / 2 mL in 1... | Midazolam | Hospira, Inc. | 2025-01-27 |
| 00409-2305-05 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-2305-05) / 5 mL in 1... | Midazolam | Hospira, Inc. | 2005-12-16 |
| 00409-2305-17 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-2305-17) / 2 mL in 1 V... | Midazolam | Hospira, Inc. | 2010-06-29 |
| 00409-2305-50 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-2305-50) / 5 mL in 1... | MIDAZOLAM | Hospira, Inc. | 2005-09-22 |
| 00409-2308-01 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-2308-01) / 1 mL in 1... | Midazolam | Hospira, Inc. | 2005-06-14 |
| 00409-2308-02 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-2308-02) / 2 mL in 1... | Midazolam | Hospira, Inc. | 2005-10-04 |
| 00409-2308-49 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-2308-49) / 1 mL in 1... | MIDAZOLAM | Hospira, Inc. | 2005-12-28 |
| 00409-2308-50 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-2308-50) / 2 mL in 1... | MIDAZOLAM | Hospira, Inc. | 2005-11-21 |
| 42571-0414-87 | 25 VIAL in 1 CARTON (42571-414-87) / 2 mL in 1 VIAL (42571-... | Midazolam | Micro Labs Limited | 2024-01-01 |
| 42571-0415-72 | 10 VIAL in 1 CARTON (42571-415-72) / 1 mL in 1 VIAL (42571-... | Midazolam | Micro Labs Limited | 2024-01-01 |
| 42571-0415-91 | 10 VIAL in 1 CARTON (42571-415-91) / 2 mL in 1 VIAL (42571-... | Midazolam | Micro Labs Limited | 2024-01-01 |
| 83270-0170-10 | 10 VIAL in 1 CARTON (83270-170-10) / 2 mL in 1 VIAL | Midazolam | Onesource Specialty Pharma Limited | 2026-02-27 |
| 83270-0171-10 | 10 VIAL in 1 CARTON (83270-171-10) / 5 mL in 1 VIAL | Midazolam | Onesource Specialty Pharma Limited | 2026-02-27 |
| 83270-0172-10 | 10 VIAL in 1 CARTON (83270-172-10) / 1 mL in 1 VIAL | Midazolam | Onesource Specialty Pharma Limited | 2026-02-27 |
| 83270-0173-10 | 10 VIAL in 1 CARTON (83270-173-10) / 2 mL in 1 VIAL | Midazolam | Onesource Specialty Pharma Limited | 2026-02-27 |
Observed labelers:
Hospira, Inc. (8) ·
Onesource Specialty Pharma Limited (4) ·
Micro Labs Limited (3) ·
Henry Schein, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2250 | Inj midazolam hydrochloride | 10 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.